Study Links cGAS to Cancer Cholesterol Control

UNC Lineberger researchers found a nuclear role for the cGAS protein that influences tumor growth and chemotherapy response.

Updated on Nov. 3, 2026 in Cancer

Clear glass culture flasks of pale amber liquid on a steel lab bench beside a centrifuge, with soft daylight from tall windows in a university laboratory. — UNC Lineberger researchers found that the cGAS protein acts inside the cell nucleus to regulate cholesterol production and tumor growth, published in the Journal of Clinical Investigation. AI Illustration. Upload story photo >

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center discovered that the cGAS protein regulates genes in the cell nucleus. The finding, published in the Journal of Clinical Investigation, shows cGAS also affects cholesterol metabolism and tumor growth.

Why it matters

The work suggests cGAS influences how cancer cells use cholesterol and how they resist treatment. Because cholesterol metabolism is involved in many diseases, the findings may extend beyond cancer.

The results come from mouse models and laboratory cell experiments, with tumors lacking cGAS growing significantly faster than controls. Whether the same cholesterol-linked mechanism operates in human tumors has not been established in the findings reported.

The players

University of North Carolina Lineberger Comprehensive Cancer Center

A National Cancer Institute-designated cancer center at UNC-Chapel Hill that conducts research on cancer biology and treatment.

The details

cGAS binds to specific regions of the genome and helps control which genes are switched on or off, and it is recruited there by proteins that regulate cell growth and stress responses. Through increasing production of the protein LGALS3, cGAS reduces production of acetyl-CoA, a building block of cholesterol, and cells lacking cGAS accumulated excess cholesterol.

November 2, 2026: Findings published in the Journal of Clinical Investigation.

Big Picture

Prior cGAS research centered on its role in the cytoplasm as a DNA sensor driving the STING immune pathway. This finding adds a nuclear function, placing cGAS in the regulation of cholesterol metabolism and cancer treatment resistance.

The findings currently apply to laboratory and mouse research, so they do not yet change treatment options for patients. Patients receiving chemotherapy should continue following their oncologists' guidance while researchers evaluate whether cGAS-linked pathways can be targeted.

The takeaway

Cholesterol metabolism appears to be a link between a cell's genetic regulation and its ability to resist treatment. Future research on this pathway may inform how clinicians approach tumors that respond poorly to chemotherapy.